Literature DB >> 9795119

Expression of complement C4 and C9 genes by human astrocytes.

D G Walker1, S U Kim, P L McGeer.   

Abstract

Evidence exists that complement activation is involved in the pathogenesis of Alzheimer's disease (AD). It has been previously demonstrated that central nervous system (CNS) resident cells can synthesize complement proteins. Two key proteins in the complement pathway are the complement C4 and C9 proteins. Using reverse transcription-polymerase chain reaction, ELISA, immunocytochemical and immunoblot techniques, we showed that primary human astrocytes constitutively expressed complement C4 mRNA and protein, and that this was increased when cells were treated with interferon-gamma, but inhibited when cells were treated with interleukin-1beta (IL-1beta). C4 immunoreactivity could be localized to GFAP-positive astrocytes when protein secretion was inhibited. These results indicated that astrocytes could be a source of complement C4 in the human CNS. In addition it was shown that stimulated astrocytes could also express complement C9 mRNA, though C9 protein was not detectable in culture supernatants. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795119     DOI: 10.1016/s0006-8993(98)00811-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

Review 1.  Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Authors:  Philippe Gasque; Jim W Neal; Sim K Singhrao; Eamon P McGreal; Yann D Dean; Beek Johan Van; B Paul Morgan
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

Review 2.  The Role of Complement C3a Receptor in Stroke.

Authors:  Saif Ahmad; Kanchan Bhatia; Adam Kindelin; Andrew F Ducruet
Journal:  Neuromolecular Med       Date:  2019-05-17       Impact factor: 3.843

Review 3.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

Review 4.  The major histocompatibility complex and autism spectrum disorder.

Authors:  Leigh A Needleman; A Kimberley McAllister
Journal:  Dev Neurobiol       Date:  2012-08-23       Impact factor: 3.964

5.  Association of complement component 4 with neuroimmune abnormalities in the subventricular zone in schizophrenia and autism spectrum disorders.

Authors:  Ta-Chung M Mou; Malcolm V Lane; Derek D C Ireland; Daniela Verthelyi; Leonardo H Tonelli; Sarah M Clark
Journal:  Neurobiol Dis       Date:  2022-08-19       Impact factor: 7.046

6.  Cell type-specific inference of differential expression in spatial transcriptomics.

Authors:  Rafael A Irizarry; Fei Chen; Dylan M Cable; Evan Murray; Vignesh Shanmugam; Simon Zhang; Luli S Zou; Michael Diao; Haiqi Chen; Evan Z Macosko
Journal:  Nat Methods       Date:  2022-09-01       Impact factor: 47.990

7.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

8.  Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease.

Authors:  Douglas G Walker; Jessica E Dalsing-Hernandez; Lih-Fen Lue
Journal:  Microvasc Res       Date:  2007-11-01       Impact factor: 3.514

9.  Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Authors:  Hong Lian; Alexandra Litvinchuk; Angie C-A Chiang; Nadia Aithmitti; Joanna L Jankowsky; Hui Zheng
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

10.  Microglia, Alzheimer's disease, and complement.

Authors:  Helen Crehan; John Hardy; Jennifer Pocock
Journal:  Int J Alzheimers Dis       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.